KCC-07
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-131031-1MG | 1 mg | 69,00 | Add | |
| HY-131031-5MG | 5 mg | 132,00 | Add | |
| HY-131031-1ML | 10mM/1mL | 178,00 | Add | |
| HY-131031-10MG | 10 mg | 222,00 | Add | |
| HY-131031-25MG | 25 mg | 432,00 | Add | |
| HY-131031-50MG | 50 mg | 682,00 | Add | |
| HY-131031-100MG | 100 mg | 1'059,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
KCC-07 is a potent, selective and brain-penetrant MBD2 (methyl-CpG-binding domain protein 2) inhibitor. KCC-07 prevents binding of MBD2 to methylated DNA and activates brain specific angiogenesis inhibitor 1 (BAI1) inducing anti-proliferative BAI1/p53/p21 signaling. Anticancer activity[1].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Cell Cycle/DNA Damage |
| Format | Solubility: DMSO : 125 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.57% |
| Molecular Formula | C14H11N3OS |
| Molecular Weight | 269.32 |
| CAS-Number | 315702-75-1 |
| Storage Conditions | 4°C (Powder, protect from light) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
